Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

SALBUTAMOL

All products: Limited Use (codes 265, 266, 267, 268)

Other products in the same Health Canada class (R03A, R03AC) — coverage varies; not interchangeable

  • Terbutaline (Bricanyl Turbuhaler): general benefit
  • Formoterol (Foradil): limited Use 132
  • Formoterol (Oxeze Turbuhaler): limited Use 132
  • Indacaterol (Onbrez Breezhaler): limited Use 443
  • Salmeterol (SereVent Diskus): limited Use 132, 391
  • Aclidinium + formoterol (Duaklir Genuair): limited Use 459

8 more in the class list below

PMS-Salbutamol · DIN 02208237 · 2mg/mL · Inh Sol- 2.5mL Pk

Limited Use — Reason for Use code 265, 266, 267, 268 requiredMarketed · checked 2026-09-19
StatusLimited Use — Reason for Use code 265, 266, 267, 268 required
Write on scriptLU code 265, 266, 267, 268 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 265, 266, 267, 268
Coverage limit: For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler. Reason for Use code 265 Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have a tracheostomy; Coverage limit: LU Authorization Period: Indefinite Reason for Use code 266 Individuals must have a known hypersensitivity to the preservative in the bulk solution, and be patients with cystic fibrosis in whom nebulizer therapy is indicated;. Coverage limit: LU Authorization Period: Indefinite Reason for Use code 267 Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have severe mental or physical disabilities; Coverage limit: LU Authorization Period: Indefinite Reason for Use code 268 Patients who have previously used nebulizer therapy within the last 12 month period. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Salbutamol · DIN 02208237 Manufacturer: Pharmascience Inc.; listing date 1997-04-10 Health Canada: Marketed since 2010-05-07 · brand PMS-SALBUTAMOL · ATC R03AC02 SALBUTAMOL · form Solution · route Inhalation · ingredients SALBUTAMOL (SALBUTAMOL SULFATE) 2 MG/ML · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PMS-Salbutamol: Formulary list price $0.6750/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.6750 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19762 · Verify on the e-Formulary ↗ (DIN 02208237)

Source record
DIN 02208237: PMS-Salbutamol Raw flags: sec12=Y, sec3=Y Item: 121200070; group id 233; item number 0413; lccId 00041; manufacturer id PMS Source form: Inh Sol- 2.5mL Pk; strength: 2mg/mL Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $0.6750; ministry $0.6750 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02208237 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19762
Interchangeable products
Teva-Salbutamol Sterinebs P.F. · DIN 02173360 · $0.6750 Ventolin Nebules P.F. · DIN 02213427 · not recorded
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (12:12 Sympathomimetic (Adrenergic) Agents) and how they are covered

Matched class: 12:12 Sympathomimetic (Adrenergic) Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: EPINEPHRINE HCL, TERBUTALINE SULFATE Some products covered without a code (check the product listing): ORCIPRENALINE SULFATE 12:12 Sympathomimetic (Adrenergic) Agents

TERBUTALINE SULFATE

· 2 products · General benefit · strengths: 0.5mg/Dose · Inh-100 Dose Pk, Inh-120 Dose Pk

FORMOTEROL FUMARATE

· 1 products · Limited Use, codes 132 · strengths: 12mcg/Cap · Inh Pd-Device Pk

FORMOTEROL FUMARATE DIHYDRATE

· 2 products · Limited Use, codes 132 · strengths: 6mcg/Metered Dose, 12mcg/Metered Dose · Pd Inh-60 Dose Pk

INDACATEROL

· 1 products · Limited Use, codes 443 · strengths: 75mcg · Inh Pd-Cap

SALMETEROL XINAFOATE

· 1 products · Limited Use, codes 132, 391 · strengths: 50mcg · Pd Inh-60 Dose Pk

ACLIDINIUM BROMIDE & FORMOTEROL FUMARATE DIHYDRATE

· 1 products · Limited Use, codes 459 · strengths: 400mcg & 12mcg · Metered Dose Pd Inh-60 Dose Pk

BUDESONIDE & FORMOTEROL FUMARATE DIHYDRATE

· 2 products · Limited Use, codes 330 · strengths: 100mcg/6mcg, 200mcg/6mcg · Pd Inh-120 Dose Pk

BUDESONIDE&GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE)&FORMOTEROL FUMARATE DIHYDRATE

· 1 products · Limited Use, codes 638 · strengths: 160mcg & 7.2mcg & 5mcg/Act · Metered Dose Inh-120 Dose Pk

FLUTICASONE FUROATE & UMECLIDINIUM BROMIDE & VILANTEROL TRIFENATATE

· 1 products · Limited Use, codes 567 · strengths: 100mcg & 62.5mcg & 25mcg · Pd Inh-30 Dose Pk

FLUTICASONE FUROATE & VILANTEROL

· 2 products · Limited Use, codes 330, 456 (1), Limited Use, codes 330 (1) · strengths: 100mcg & 25mcg, 200mcg & 25mcg · Blister Pd Inh-30 Dose Pk

INDACATEROL & GLYCOPYRRONIUM

· 1 products · Limited Use, codes 459 · strengths: 110mcg & 50mcg · Inh Pd-Cap

MOMETASONE FUROATE & FORMOTEROL FUMARATE DIHYDRATE

· 2 products · Limited Use, codes 330 · strengths: 100mcg & 5mcg, 200mcg & 5mcg · Metered Dose Inh-120 Dose Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 12:12 and 4 more
Full class listing Related classes: 12:04 Parasympathomimetic (Cholinergic) Agents, 12:08 Parasympatholytic (Cholinergic Blocking) Agents, 12:20 Skeletal Muscle Relaxants Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE TEVA-SALBUTAMOL STERINEBSTM P.F. (salbutamol sulphate Solution) is indicated for: • the treatment of severe bronchospasm associated with exacerbations of chronic bronchitis and bronchial asthma. It can be used by “wet” nebulization. When administered through a nebulizer, it should be used with compressed air or oxygen. Pediatrics (< 5 years of age): Experience is insufficient for recommending the treatment of children under 5 years of age. https://pdf.hres.ca/dpd_pm/00084629.PDF PM date: October 28, 2022 Source product: TEVA-SALBUTAMOL STERINEBS P.F.; DIN 01926934; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.